Multicentre study of multidisciplinary team assessment of pancreatic cancer resectability and treatment allocation

J Kirkegård*, E K Aahlin, M Al-Saiddi, S O Bratlie, M Coolsen, R J de Haas, M den Dulk, C Fristrup, E M Harrison, M B Mortensen, M W Nijkamp, J Persson, J A Søreide, S J Wigmore, T Wik, F V Mortensen

*Kontaktforfatter for dette arbejde

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

    19 Downloads (Pure)

    Abstrakt

    BACKGROUND: Multidisciplinary team (MDT) meetings have been adopted widely to ensure optimal treatment for patients with cancer. Agreements in tumour staging, resectability assessments and treatment allocation between different MDTs were assessed.

    METHODS: Of all patients referred to one hospital, 19 patients considered to have non-metastatic pancreatic cancer for evaluation were selected randomly for a multicentre study of MDT decisions in seven units across Northern Europe. Anonymized clinical information and radiological images were disseminated to the MDTs. All patients were reviewed by the MDTs for radiological T, N and M category, resectability assessment and treatment allocation. Each MDT was blinded to the decisions of other teams. Agreements were expressed as raw percentages and Krippendorff's α values, both with 95 per cent confidence intervals.

    RESULTS: A total of 132 evaluations in 19 patients were carried out by the seven MDTs (1 evaluation was excluded owing to technical problems). The level of agreement for T, N and M categories ranged from moderate to near perfect (46·8, 61·1 and 82·8 per cent respectively), but there was substantial variation in assessment of resectability; seven patients were considered to be resectable by one MDT but unresectable by another. The MDTs all agreed on either a curative or palliative strategy in less than half of the patients (9 of 19). Only fair agreement in treatment allocation was observed (Krippendorff's α 0·31, 95 per cent c.i. 0·16 to 0·45). There was a high level of agreement in treatment allocation where resectability assessments were concordant.

    CONCLUSION: Considerable disparities in MDT evaluations of patients with pancreatic cancer exist, including substantial variation in resectability assessments.

    OriginalsprogEngelsk
    TidsskriftThe British journal of surgery
    Vol/bind106
    Udgave nummer6
    Sider (fra-til)756-764
    ISSN0007-1323
    DOI
    StatusUdgivet - maj 2019

    Bibliografisk note

    © 2019 BJS Society Ltd Published by John Wiley & Sons Ltd.

    Fingeraftryk Dyk ned i forskningsemnerne om 'Multicentre study of multidisciplinary team assessment of pancreatic cancer resectability and treatment allocation'. Sammen danner de et unikt fingeraftryk.

    Citationsformater